Exam 5 (final) - Watts Antidepressants Flashcards
brain-derived neurotrophic factor (BDNF) effect on depression (neurotrophic hypothesis)
stress and pain decrease BDNF levels in animals
-has antidepressant activities in animals
-depressed pts have less BDNF
-antidepressant meds increase BDNF
-some drugs cause decreased BDNF levels (glucocorticoids)
targets of fluoxetine and trazodone
5HT-2 reuptake receptors
targets of desipramine and maprotiline
NE reuptake receptors
targets of MAOi
MAO (block conversion to metabolites?)
Why is there a delay in clinical effect for some antidepressants?
-reason that therapy takes about 2-3 weeks before effectiveness
reason is not really known for sure
mechanism of MAOis
inhibit Monoamine Oxydase in presynaptic neuron
-importance of this is NE and 5HT is normally degraded by MAO
-now more 5HT and NE is released from vesicles into synapse
MAO inhibitors “severe” SE
HA
drowsiness
dry mouth
weight gain
orthostatic hypotension
sexual dysfxn
MAOi clinical pearls
avoid foods with tyramine (many but some examples are cheeses, sour cream, liver, lots of meats like pepperoni, beer, red wine, avocados, bananas)
tricyclic antidepressants (tertiary amines) MOA
inhibit both NE and 5HT reuptake via NET and SERT
tricyclic antidepressants (tertiary amines) SE
sedation (most of any class for depression)
weight gain (most of any class for depression)
heart conduction disturbances
tricyclic antidepressants (tertiary amines) options
imipramine (Tofranil)
amitriptyline (Elavil)
trimipramine (Surmontil)
clomipramine (Anafranil)
doxepin (Adapin, Sinequan)
tricyclic antidepressants (secondary amines) options
desipramine (Norpramin)
nortriptyline (Pamelor)
pretriptyline (Vivactil)
maprotiline (Ludiomil)
tricyclic antidepressants (secondary amines) SE
less but still some of:
sedation
weight gain
anticholinergic effects
autonomic effects
cardiovascular effects
general all TCA SE
weight gain
anticholinergic effects
neuro
CV (in elderly)
SSRIs MOA
inhibit 5HT presynaptic neuron receptors
-increases amount of 5HT in synapse
-5HT in synapse stays there longer and remains active longer
SSRIs options
fluoxetine (Prozac)
fluvoxamine (Luvox)
paroxetine (Paxil)
sertraline (Zoloft)
citalopram (Celexa)
escitalopram oxalate (Lexapro)
which SSRI has less autonomic SE and no sedation compared to other SSRIs
fluoxetine
SSRI SE
NV
HA
sexual dysfxn
anxiety
insomnia
tremor
abrupt SSRI d/c can lead to
withdrawal sx:
brain zaps
dizziness
sweating
N
insomnia
tremor
confusion
vertigo
drugs when used in combo may cause serotonin syndrome
SSRIs
MAOis
TCAs
metoclopramide
tramadol
triptans
St. John’s Wort
SSRI + 5HT1A partial agonists options
vilazodone (Viibryd)
vortioxetine (Brintellex)
tetracyclic TCA
mirtazapine (Remeron)
-alpha2 antagonist
-5HT2 and 3 antagonist
-H1 antagonist
unicyclic TCA
bupropion (Wellbutrin)
-DAT inhibitor
-NET and SERT inhibitor
5HT2 antagonist/SERT inhibitor
trazodone (Dyserel)
-5HT2a antagonist
-weak SERT inhibitor
SNRIs options
venlafaxine (Effexor)
desvenlafaxine (Pristiq)
duloxetine (Cymbalta)
milnacipran (Ixel)
levomilnacipran (Fetzima)
reboxetine (Vestra, Edronax)
atomoxetine (Straterra)
more rapid acting antidepressants include what class
NMDA antagonists
NMDA antagonists options
ketamine (subanesthetic doses)
eskatamine (expensive)
tx for postpartum depression (PPD)
SSRIs: fluoxetine, paroxetine
SNRIs: venlafaxine
GABA-A modulators: brexanolone (Zulresso)
CBT
brexanolone (Zulresso) MOA
-allopregnanolone levels increase during pregnancy
-GABA-A receptors become desensitized
-allopregnanolone levels return to normal postpartum
-brexanolone resensitizes GABA-A receptors
brexanolone (Zulresso) clinical pearls
REMS drug
60hr infusion
$20,000-30,000 + hospital costs
flibanserin (Addyi)
-developed as antidepressant but now use for hypoactive sexual desire disorder
-agonist at 5HT1A
-antagonist at 5HT2A/C
how does reserpine cause depression (“biogenic amine” hypothesis)
depletes NE and 5HT from vesicles
describe 3 steps of neuroendocrine hypothesis
changes in hypothalamic-pituitary-adrenal (HPA) axis
-stress causes hypothalamus to release corticotropin releasing factor (CRF)
-CRF promotes release of ACTH from pituitary
-ACTH promotes release of cortisol from adrenal
just know elevated CRF causes depression
CRF acts on CRF1 receptors to cause:
arousal
anxiety
disruption of sexual behaviors
disruption of sleep